← Back to Clinical Trials
Recruiting NCT06913335

NCT06913335 Comparison Between Electrosurgical Energy and Hemostatic Sealants on Hemostasis in Laparoscopic Ovarian Cystectomy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06913335
Status Recruiting
Phase
Sponsor Kafrelsheikh University
Condition Ovarian Cysts
Study Type INTERVENTIONAL
Enrollment 58 participants
Start Date 2025-04-01
Primary Completion 2026-04-01

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 50 Years
Study Type INTERVENTIONAL
Interventions
laparoscopic ovarian cystectomy using hemostatic sealantlaparoscopic ovarian cystectomy using electrosurgical energy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 58 participants in total. It began in 2025-04-01 with a primary completion date of 2026-04-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this study is to compare between the effect of using electrosurgical energy and hemostatic sealant for hemostasis in laparoscopic cystectomy for ovarian cysts.

Eligibility Criteria

Inclusion Criteria: * Age ≥ 18 years old. * Women with unilateral or bilateral benign ovarian cyst provisionally diagnosed by ultrasound and normal tumor markers. * Women fit for laparoscopic surgery Exclusion Criteria: * Pregnant women. * Postmenopausal women. * Premenarchal girls. * Women with a history of recent pelvic or abdominal radiotherapy. * Women with serious concurrent systemic disorders. * Known ovarian malignancy provisionally diagnosed by ultrasound (US) or tumor markers. * Women with coagulopathy or bleeding disorders.

Contact & Investigator

Central Contact

Aya Yasser Fawzy, M.B.B.C.H

✉ yaya86438@gmail.com

📞 01097659005

Frequently Asked Questions

Who can join the NCT06913335 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 50 Years, studying Ovarian Cysts. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06913335 currently recruiting?

Yes, NCT06913335 is actively recruiting participants. Contact the research team at yaya86438@gmail.com for enrollment information.

Where is the NCT06913335 trial being conducted?

This trial is being conducted at Kafr ash Shaykh, Egypt.

Who is sponsoring the NCT06913335 clinical trial?

NCT06913335 is sponsored by Kafrelsheikh University. The trial plans to enroll 58 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology